Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Antibody Drug Conjugates (ADCs) 1.4.3 Bispecific Antibodies (BsAbs) 1.4.4 Fc Engineered Antibodies 1.4.5 Antibody Fragments and Antibody-Like Proteins (AF & ALPs) 1.4.6 Biosimilar Antibody (Ab) Products 1.5 Market by Application 1.5.1 Global Next Generation Antibody Therapeutics Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Next Generation Antibody Therapeutics Market Size 2.2 Next Generation Antibody Therapeutics Growth Trends by Regions 2.2.1 Next Generation Antibody Therapeutics Market Size by Regions (2014-2025) 2.2.2 Next Generation Antibody Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Next Generation Antibody Therapeutics Market Size by Manufacturers 3.1.1 Global Next Generation Antibody Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Next Generation Antibody Therapeutics Key Players Head office and Area Served 3.3 Key Players Next Generation Antibody Therapeutics Product/Solution/Service 3.4 Date of Enter into Next Generation Antibody Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Next Generation Antibody Therapeutics Market Size by Type (2014-2019) 4.2 Global Next Generation Antibody Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Next Generation Antibody Therapeutics Market Size (2014-2019) 5.2 Next Generation Antibody Therapeutics Key Players in United States 5.3 United States Next Generation Antibody Therapeutics Market Size by Type 5.4 United States Next Generation Antibody Therapeutics Market Size by Application 6 Europe 6.1 Europe Next Generation Antibody Therapeutics Market Size (2014-2019) 6.2 Next Generation Antibody Therapeutics Key Players in Europe 6.3 Europe Next Generation Antibody Therapeutics Market Size by Type 6.4 Europe Next Generation Antibody Therapeutics Market Size by Application 7 China 7.1 China Next Generation Antibody Therapeutics Market Size (2014-2019) 7.2 Next Generation Antibody Therapeutics Key Players in China 7.3 China Next Generation Antibody Therapeutics Market Size by Type 7.4 China Next Generation Antibody Therapeutics Market Size by Application 8 Japan 8.1 Japan Next Generation Antibody Therapeutics Market Size (2014-2019) 8.2 Next Generation Antibody Therapeutics Key Players in Japan 8.3 Japan Next Generation Antibody Therapeutics Market Size by Type 8.4 Japan Next Generation Antibody Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Next Generation Antibody Therapeutics Market Size (2014-2019) 9.2 Next Generation Antibody Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Next Generation Antibody Therapeutics Market Size by Type 9.4 Southeast Asia Next Generation Antibody Therapeutics Market Size by Application 10 India 10.1 India Next Generation Antibody Therapeutics Market Size (2014-2019) 10.2 Next Generation Antibody Therapeutics Key Players in India 10.3 India Next Generation Antibody Therapeutics Market Size by Type 10.4 India Next Generation Antibody Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Next Generation Antibody Therapeutics Market Size (2014-2019) 11.2 Next Generation Antibody Therapeutics Key Players in Central & South America 11.3 Central & South America Next Generation Antibody Therapeutics Market Size by Type 11.4 Central & South America Next Generation Antibody Therapeutics Market Size by Application 12 International Players Profiles 12.1 Pfizer 12.1.1 Pfizer Company Details 12.1.2 Company Description and Business Overview 12.1.3 Next Generation Antibody Therapeutics Introduction 12.1.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.1.5 Pfizer Recent Development 12.2 Roche 12.2.1 Roche Company Details 12.2.2 Company Description and Business Overview 12.2.3 Next Generation Antibody Therapeutics Introduction 12.2.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.2.5 Roche Recent Development 12.3 Bristol-Myers Squibb 12.3.1 Bristol-Myers Squibb Company Details 12.3.2 Company Description and Business Overview 12.3.3 Next Generation Antibody Therapeutics Introduction 12.3.4 Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.3.5 Bristol-Myers Squibb Recent Development 12.4 Amgen 12.4.1 Amgen Company Details 12.4.2 Company Description and Business Overview 12.4.3 Next Generation Antibody Therapeutics Introduction 12.4.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.4.5 Amgen Recent Development 12.5 AstraZeneca 12.5.1 AstraZeneca Company Details 12.5.2 Company Description and Business Overview 12.5.3 Next Generation Antibody Therapeutics Introduction 12.5.4 AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.5.5 AstraZeneca Recent Development 12.6 Bayer 12.6.1 Bayer Company Details 12.6.2 Company Description and Business Overview 12.6.3 Next Generation Antibody Therapeutics Introduction 12.6.4 Bayer Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.6.5 Bayer Recent Development 12.7 Takeda Pharmaceuticals 12.7.1 Takeda Pharmaceuticals Company Details 12.7.2 Company Description and Business Overview 12.7.3 Next Generation Antibody Therapeutics Introduction 12.7.4 Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.7.5 Takeda Pharmaceuticals Recent Development 12.8 Biogen 12.8.1 Biogen Company Details 12.8.2 Company Description and Business Overview 12.8.3 Next Generation Antibody Therapeutics Introduction 12.8.4 Biogen Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.8.5 Biogen Recent Development 12.9 Seattle Genetics 12.9.1 Seattle Genetics Company Details 12.9.2 Company Description and Business Overview 12.9.3 Next Generation Antibody Therapeutics Introduction 12.9.4 Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.9.5 Seattle Genetics Recent Development 12.10 ImmunoGen 12.10.1 ImmunoGen Company Details 12.10.2 Company Description and Business Overview 12.10.3 Next Generation Antibody Therapeutics Introduction 12.10.4 ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2014-2019) 12.10.5 ImmunoGen Recent Development 12.11 Kyowa Hakko Kirin 12.12 Xencor 12.13 Dyax Corp 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Next Generation Antibody Therapeutics Key Market Segments Table Key Players Next Generation Antibody Therapeutics Covered Table Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Type 2014-2025 Figure Antibody Drug Conjugates (ADCs) Figures Table Key Players of Antibody Drug Conjugates (ADCs) Figure Bispecific Antibodies (BsAbs) Figures Table Key Players of Bispecific Antibodies (BsAbs) Figure Fc Engineered Antibodies Figures Table Key Players of Fc Engineered Antibodies Figure Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Figures Table Key Players of Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Figure Biosimilar Antibody (Ab) Products Figures Table Key Players of Biosimilar Antibody (Ab) Products Table Global Next Generation Antibody Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Others Case Studies Figure Next Generation Antibody Therapeutics Report Years Considered Table Global Next Generation Antibody Therapeutics Market Size 2014-2025 (Million US$) Figure Global Next Generation Antibody Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Next Generation Antibody Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Next Generation Antibody Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Next Generation Antibody Therapeutics Market Share by Regions 2014-2019 Figure Global Next Generation Antibody Therapeutics Market Share by Regions 2014-2019 Figure Global Next Generation Antibody Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Next Generation Antibody Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Next Generation Antibody Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Next Generation Antibody Therapeutics Market Share by Manufacturers in 2018 Table Global Next Generation Antibody Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Next Generation Antibody Therapeutics Product/Solution/Service Table Date of Enter into Next Generation Antibody Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Next Generation Antibody Therapeutics Market Size Share by Type (2014-2019) Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Type (2014-2019) Table Global Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Next Generation Antibody Therapeutics Market Size Share by Application (2014-2019) Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Next Generation Antibody Therapeutics Revenue Market Share by Application in 2018 Figure United States Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Next Generation Antibody Therapeutics Market Share (2018-2019) Table United States Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Next Generation Antibody Therapeutics Market Share by Type (2014-2019) Table United States Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Next Generation Antibody Therapeutics Market Share by Application (2014-2019) Figure Europe Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Next Generation Antibody Therapeutics Market Share (2018-2019) Table Europe Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Next Generation Antibody Therapeutics Market Share by Type (2014-2019) Table Europe Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Next Generation Antibody Therapeutics Market Share by Application (2014-2019) Figure China Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Next Generation Antibody Therapeutics Market Share (2018-2019) Table China Next Generation Antibody Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Next Generation Antibody Therapeutics Market Share by Type (2014-2019) Table China Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Next Generation Antibody Therapeutics Market Share by Application (2014-2019) Figure Japan Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Next Generation Antibody Therapeutics Market Share (2018-2019) Table Japan Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Next Generation Antibody Therapeutics Market Share by Type (2014-2019) Table Japan Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Next Generation Antibody Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Next Generation Antibody Therapeutics Market Share (2018-2019) Table Southeast Asia Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Next Generation Antibody Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Next Generation Antibody Therapeutics Market Share by Application (2014-2019) Figure India Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Next Generation Antibody Therapeutics Market Share (2018-2019) Table India Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Next Generation Antibody Therapeutics Market Share by Type (2014-2019) Table India Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Next Generation Antibody Therapeutics Market Share by Application (2014-2019) Figure Central & South America Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Next Generation Antibody Therapeutics Market Share (2018-2019) Table Central & South America Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Next Generation Antibody Therapeutics Market Share by Type (2014-2019) Table Central & South America Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Next Generation Antibody Therapeutics Market Share by Application (2014-2019) Table Pfizer Company Details Table Pfizer Revenue in Next Generation Antibody Therapeutics Business (2014-2019) (Million US$) Figure Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Pfizer Recent Development Table Roche Company Details Table Roche Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Roche Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Amgen Company Details Table Amgen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Amgen Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table AstraZeneca Recent Development Table Bayer Company Details Table Bayer Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure Bayer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Bayer Recent Development Table Takeda Pharmaceuticals Company Details Table Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure Takeda Pharmaceuticals Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Takeda Pharmaceuticals Recent Development Table Biogen Company Details Table Biogen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure Biogen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Biogen Recent Development Table Seattle Genetics Company Details Table Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure Seattle Genetics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table Seattle Genetics Recent Development Table ImmunoGen Company Details Table ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$) Figure ImmunoGen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019) Table ImmunoGen Recent Development Table Kyowa Hakko Kirin Company Details Table Xencor Company Details Table Dyax Corp Company Details Table Global Next Generation Antibody Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Next Generation Antibody Therapeutics Market Size Share by Regions (2019-2025) Figure Global Next Generation Antibody Therapeutics Market Size Share by Regions in 2025 Figure United States Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Next Generation Antibody Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Next Generation Antibody Therapeutics Market Size by Product (2019-2025) Figure Global Next Generation Antibody Therapeutics Market Size by Product in 2025 Table Global Next Generation Antibody Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Next Generation Antibody Therapeutics Market Size by Application (2019-2025) Figure Global Next Generation Antibody Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Roche Bristol-Myers Squibb Amgen AstraZeneca Bayer Takeda Pharmaceuticals Biogen Seattle Genetics ImmunoGen Kyowa Hakko Kirin Xencor Dyax Corp